Transvaginal approach combined intracavitary and interstitial brachytherapy assisted by transrectal ultrasound: results from 30 patients with locally advanced cervical cancer

Jpn J Radiol. 2024 Jan;42(1):96-101. doi: 10.1007/s11604-023-01481-4. Epub 2023 Aug 17.

Abstract

Purpose: This study evaluated the efficacy and safety of transvaginal approach combined intracavitary and interstitial brachytherapy (IC/IS BT) assisted by transrectal ultrasound (TRUS) for treatment of locally advanced cervical cancer (LACC).

Materials and methods: A total of 30 patients of LACC treated with external beam radiotherapy and IC/IS BT via transvaginal approach assisted by transrectal ultrasound were observed retrospectively. The 2-year local control (LC), progression-free survival (PFS), and overall survival (OS) were analyzed using the Kaplan-Meier method. Late adverse events were also evaluated to assess the safety of IC/IS BT.

Results: The median follow-up period was 22 months. The 2-year LC, PFS, and OS were 90%, 61%, and 82%, respectively. We observed no critical complications related to the IC/IS BT technique. Late adverse events of grade 3 or more included one case of grade 4 colon perforation.

Conclusion: Our patient series demonstrated that radiotherapy combined with transvaginal approach, TRUS-assisted IC/IS BT achieves favorable local control and safety for LACC.

Keywords: Cervical cancer; Hybrid brachytherapy; Intracavitary and interstitial brachytherapy; Transrectal ultrasound; Transvaginal approach.

MeSH terms

  • Brachytherapy* / methods
  • Female
  • Humans
  • Radiotherapy Dosage
  • Radiotherapy Planning, Computer-Assisted / methods
  • Retrospective Studies
  • Uterine Cervical Neoplasms* / diagnostic imaging
  • Uterine Cervical Neoplasms* / radiotherapy